STOCK TITAN

Cavitation Technologies (CVAT) Stock News

CVAT OTC

Welcome to our dedicated page for Cavitation Technologies news (Ticker: CVAT), a resource for investors and traders seeking the latest updates and insights on Cavitation Technologies stock.

Cavitation Technologies, Inc. reports developments around its fluid-processing technology business and its expansion into water treatment and digital payment infrastructure. The company designs and manufactures flow-through nano-technology systems for fluid processing applications, including Nano Reactor® systems and Cavitation Non-Thermal Plasma™ technology for water treatment, remediation, PFAS removal, and other industrial uses.

Recurring updates include pilot and partnership activity for cavitation-based systems, subsidiary developments at XYRA Corp., license agreements and market expansion for remittances, fintech, and crypto-asset transactions, and governance changes. CVAT announcements also reference shareholder voting matters, capital-structure disclosures, material agreements, and board or advisory roles tied to its operating subsidiaries and technology commercialization efforts.

Rhea-AI Summary

Cavitation Technologies, Inc. (CVAT) has entered into an agreement with Desmet Belgium S.A. to monetize certain patents and intellectual property related to vegetable oil, fats, and oleo applications. CTi will assign and transfer several U.S. and non-U.S. patents and two trademark registrations to Desmet. However, CTi will retain exclusive, worldwide licenses for using the assigned patents in water and wastewater processing and alcoholic beverage manufacturing.

The agreement allows CTi to monetize IP rights already licensed to Desmet while maintaining rights for its primary business lines. This transaction is expected to generate substantial capital for CTi without shareholder dilution, supporting current business plans. The deal is anticipated to be completed within ten days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.67%
Tags
conferences acquisition
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.43%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.67%
Tags
none

FAQ

What is the current stock price of Cavitation Technologies (CVAT)?

The current stock price of Cavitation Technologies (CVAT) is $0.0489 as of September 3, 2026.

What is the market cap of Cavitation Technologies (CVAT)?

The market cap of Cavitation Technologies (CVAT) is approximately 15.5M.